医学
回顾性队列研究
肝细胞癌
接收机工作特性
放射科
H&E染色
磁共振成像
超声波
免疫组织化学
曲线下面积
癌
川地34
精确检验
病变
多中心研究
外科
癌症
核医学
病理
作者
Zhehan Shen,Wanmin Liu,Xiaoming Li,Wenjie Zou,Yiman Li,Jie Yuan,Yasen Yimit,Shihang Wang,Linhao Qu,Hui Dong,Wei Chen,Ningyang Jia,Peijun Wang
摘要
Vessels encapsulating tumor clusters (VETC) are an aggressive vascular phenotype of hepatocellular carcinoma that is usually determined after surgery. A foundation model-enabled framework for pathology-informed VETC prediction on pretreatment magnetic resonance imaging (MRI), termed PIVOT, uses paired preoperative multiparametric MRI, postoperative hematoxylin and eosin whole-slide images, and CD34 immunohistochemistry during model development, while inference requires only preoperative MRI. PIVOT-MRI uses morphologic and vascular embedding alignment, and PIVOT-Clinical combines the PIVOT-MRI score with tumor size and alpha-fetoprotein. The multicenter retrospective study includes 2052 patients in a training cohort, an internal test cohort, and four external validation cohorts. PIVOT-MRI achieves an area under the receiver operating characteristic curve of 0.887 in the internal test cohort and 0.839-0.861 across external cohorts. PIVOT-Clinical increases the internal-test area under the curve to 0.904 and PIVOT-Clinical-defined groups are associated with different two-year recurrence risks. Removing both histopathologic alignment branches results in the largest ablation-related performance decrease. Exploratory radiotranscriptomic analyses showed that higher PIVOT-MRI scores were associated with angiogenesis-related, endothelial, and proliferative transcriptional programs. PIVOT enables noninvasive preoperative assessment of pathology-defined vascular aggressiveness in resectable hepatocellular carcinoma while preserving an MRI-only clinical inference pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI